Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOSUNETUZUMAB-AXGB for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where MOSUNETUZUMAB-AXGB was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for MOSUNETUZUMAB-AXGB

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 52 26.3% 2 23
Pyrexia 27 13.6% 0 16
Disease progression 25 12.6% 2 9
Off label use 20 10.1% 0 2
Rash 18 9.1% 0 1
No adverse event 16 8.1% 0 0
Neutropenia 13 6.6% 1 1
Thrombocytopenia 9 4.6% 0 0
Chills 8 4.0% 0 2
Fatigue 8 4.0% 0 3
Death 7 3.5% 7 1
Headache 7 3.5% 0 2
Klebsiella test positive 7 3.5% 0 7
Leukopenia 7 3.5% 0 0
Vomiting 7 3.5% 0 2

Other Indications for MOSUNETUZUMAB-AXGB

Follicular lymphoma (126) Product used for unknown indication (41) Follicular lymphoma refractory (5)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

MOSUNETUZUMAB-AXGB Full Profile All Diffuse large b-cell lymphoma Drugs MOSUNETUZUMAB-AXGB Demographics MOSUNETUZUMAB-AXGB Timeline